SUMITOMO PHARMA CO LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 4506 for the last quarter is 82.39 B JPY, and it's 7.06% higher compared to the previous quarter. The net income of Q3 23 is -49.97 B JPY.